LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Encora Therapeutics is developing wearable technology that will provide patients with personalized and non-invasive remedies for the management of neurological movement disorders. Other competitors developing wearables for the monitoring and rehabilitation of neurological movement disorders include Great Lakes NeuroTechnologies and ADPM Wearable Technologies.
AI-powered imaging technology developer, Subtle Medical, completes Series A Round
SubtlePET is an FDA-cleared software solution that denoises the image quality of imaging scans and reduces scan times, without compromising image quality. The amount raised during the Series A round, which was led by Nina Capital, was not disclosed. Withholding the amount raised during the recent round, Subtle Medical has raised $1.1M to-date. Other startups competing in the AI imaging software market include Arterys, Viz.ai, and Zebra Medical Vision.
Restorative Neurotechnologies is developing non-invasive neuromodulation therapies
Mindlenses is a CE Marked, non-invasive neuromodulation device for the rehabilitation of cognitive disease or enhanced sports performance. In addition to the Mindlenses platform, the company has developed modly, a free application for cognitive training. Key strategics in the neuromodulation and digital health technology market include Boston Scientific, Livongo, and Medtronic.
Cardiac Dimension closes $17.5M in Series C Financing
The company develops the Carillon Mitral Contour System, a CE Marked therapy for functional mitral regurgitation. Cardiac Dimensions stated that the funds will be used to accelerate and expand sales of the Carillon System in Europe. The device is currently being evaluated in a pivotal clinical trial in the United States. Major competitors in the transcatheter heart valve repair market include Boston Scientific, Edwards, and Medtronic.
R-Zero is offering hospital-grade surface and air disinfection using short-wave ultraviolet radiation
The R-Zero Arc is a mobile sanitation system that uses short-wave ultraviolet radiation (UV-C) that can be used in hospitals and businesses to destroy bacteria and viruses. The CDC and FDA have approved the use of UV-C for disinfection N95 and other medical equipment to prevent the spread of COVID-19. The company recently completed a Series A financing round worth $15M.
Ceryx Medical is utilizing novel microchip technologies to develop next-generation medical devices
According to Ceryx Medical, the first application for its microchip technology is to develop a cardiac pacemaker for individuals with heart failure. A study published in The Journal of Physiology found that the technology alleviated the symptoms of heart failure by restoring the body’s natural heart rhythm. Biotronik, Boston Scientific, and Medtronic are some of the key players in the cardiac resynchronization therapy market.
Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Startup Tracker.